KELLBENX
Kellbenx focuses on the development of non-invasive prenatal diagnosis for specific genetic and other heritable disorders. Its focus is to improve women's healthcare and one of our first tests is in the area of non-invasive prenatal diagnosis (NIPD) for genetic disorders. It was founded in 2010 and headquartered in Massapequa, New York.
KELLBENX
Industry:
Biotechnology Genetics Health Care Health Diagnostics
Founded:
2010-01-01
Address:
Massapequa, New York, United States
Country:
United States
Website Url:
http://www.kellbenx.com
Total Employee:
1+
Status:
Active
Contact:
631-643-2614
Total Funding:
16.71 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS GoDaddy Register.com DNS
Similar Organizations
Human Longevity
Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Employees Featured
Jonathan Herman Chief Medical Advisor @ KellBenx
Chief Medical Advisor
Leonard Kellner Chairman and President @ KellBenx
Chairman and President
Hassan Bennani CEO @ KellBenx
CEO
2010-03-01
Javad Khosravi Chief Scientific Officer, Medical Science and Cancer research @ KellBenx
Chief Scientific Officer, Medical Science and Cancer research
Founder
Investors List
HealthCor Partners
HealthCor Partners investment in Series C - KellBenx
Official Site Inspections
http://www.kellbenx.com
- Host name: 3.232.71.198.host.secureserver.net
- IP address: 198.71.232.3
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "KellBenx"
KellBenx 2025 Company Profile: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for KellBenx. Use the PitchBook Platform to explore the full profile.See details»
KellBenx - EquityNet
Founded in 2010, KellBenx, Inc. is a privately-held biotechnology company based in New York City. KellBenx is developing high value, innovative tests that leverage the ability to extract …See details»
KellBenx Company Profile - Office Locations, Competitors ... - Craft
KellBenx has 5 employees at their 1 location and $10 m in total funding,. See insights on KellBenx including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»
KellBenx - LinkedIn
KellBenx | 64 followers on LinkedIn.See details»
KellBenX - Products, Competitors, Financials, Employees, …
About KellBenX KellBenX is a biotechnolgy company developing high value tests that create unique pathways to extract clinically relevant information from blood. The company's focus is …See details»
Kellbenx Inc. Company Profile | Great River, NY | Competitors ...
Find company research, competitor information, contact details & financial data for Kellbenx Inc. of Great River, NY. Get the latest business insights from Dun & Bradstreet.See details»
KellBenx - Funding, Financials, Valuation & Investors
Kellbenx focuses on the development of non-invasive prenatal diagnosis for specific genetic and other heritable disorders.See details»
KellBenx - Crunchbase
Kellbenx focuses on the development of non-invasive prenatal diagnosis for specific genetic and other heritable disorders.See details»
KellBenx, Inc.:Company Profile & Technical Research,Competitor …
KellBenx is a company that provides Prenatal diagnosis, Medicine, Health care and more. KellBenx is headquartered in United States New York. KellBenx was founded in 2010. and …See details»
Kellbenx Inc. - BioCentury Company Profiles - BCIQ
Sep 17, 2012 Kellbenx Inc. - BioCentury Company Profiles for the biopharma industrySee details»
KellBenx - Company Profile - Tracxn
Feb 27, 2025 KellBenx - Non-invasive prenatal diagnosis for specific genetic and other heritable disorders.. This company is not active anymore. Raised a total funding of $8.34M over 6 …See details»
KellBenx Management Team | Org Chart - RocketReach
KellBenx employs 1 employees. The KellBenx management team includes Hassan Bennani (CEO), and Leonard Kellner (President and Chairman of the Board). Get Contact Info for All …See details»
KellBenx Secures $2.5 Million Funding Round - PR Newswire
NEW YORK, April 21, 2011 /PRNewswire/ -- KellBenx, a biotechnology company focused on the development of non-invasive prenatal diagnosis (NIPD) of genetic and inherited disorders, …See details»
KellBenx - Contacts, Employees, Board Members, Advisors & Alumni
Kellbenx focuses on the development of non-invasive prenatal diagnosis for specific genetic and other heritable disorders.See details»
KellBenx CEO and Key Executive Team - Craft.co
KellBenx's CEO is Hassan Bennani. Other executives include Leonard Kellner, Chairman and President; Jonathan Herman, Chief Medical Advisor and 1 others. See the full leadership team …See details»
KellBenx Genetics & Genomics News | GenomeWeb
NEW YORK (GenomeWeb News) – Non-invasive prenatal diagnostics firm KellBenX has closed on a $10 million Series C financing round, its Co-Founder and CEO Hassan Bennani …See details»
KellBenX CEO, Founder, Key Executive Team, Board of Directors
Explore {KellBenX's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»
Top 2025 NFL Draft prospect Cam Ward: 'Dream' to play for this …
3 days ago Projected No. 1 overall NFL Draft pick Cam Ward revealed the team he wants to play for most — but it’s not of the draft’s top three teams.See details»
Hassan Bennani - CEO @ KellBenx - Crunchbase Person Profile
The strength of my background includes multiple fast-track promotions to senior leadership roles within a high-growth sales organization, outstanding team building and training abilities, and …See details»
Saints hire Eagles OC Kellen Moore as head coach - ESPN
Feb 11, 2025 Eagles offensive coordinator Kellen Moore has agreed to become coach of the Saints.See details»